4 More London Riverside
+44 283 833 2200
The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally
The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IXRS®) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over almost 50 years and now employs in close to 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Europe, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).
Through our continual investment in the development of our state of the art services; from cutting edge biomarker and companion diagnostics through to step changes in the management of the clinical trial data and the clinical supply chain to biocatalytic manufacture of API, Almac ensures we are always there to support you across the product development lifecycle.
North American Headquarters:
25 Fretz Road
T: +1 (215) 660 8500
Almac Pharmaceutical Services Pte. Ltd.
9 Changi South Street 3
Unit 01-01 Singapore
T: +65 63090720
Almac Sciences is delighted to be exhibiting at Neoantigen Based Therapies Summit virtual event, taking place between 3-5 November 2020. Connect with us: https://t.co/F2CXqbBow5 pic.twitter.com/CPy4MO7oIO— Almac Group (@AlmacGroup) October 28, 2020
With 65 days to go until the end of the Brexit transition period on 31st December 2020, tune in to our recent webinar to hear how to create a robust clinical supply chain, post-transition period: https://t.co/5a0NZ3mpSy pic.twitter.com/03gCxhmUjw— Almac Group (@AlmacGroup) October 28, 2020